Hua Medicine
HKEX:2552
Hua Medicine
EPS (Diluted)
Hua Medicine
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
Hua Medicine
HKEX:2552
|
EPS (Diluted)
¥0
|
CAGR 3-Years
19%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
EPS (Diluted)
¥0
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
EPS (Diluted)
¥4
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
EPS (Diluted)
¥2
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
EPS (Diluted)
-¥1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Hua Medicine's EPS (Diluted)?
EPS (Diluted)
-0.2
CNY
Based on the financial report for Dec 31, 2023, Hua Medicine's EPS (Diluted) amounts to -0.2 CNY.
What is Hua Medicine's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
53%
Over the last year, the EPS (Diluted) growth was -5%. The average annual EPS (Diluted) growth rates for Hua Medicine have been 19% over the past three years , 53% over the past five years .